Literature DB >> 24672589

Delayed functional recovery in presymptomatic mSOD1G93A mice following facial nerve crush axotomy.

Nichole A Mesnard1, Melissa M Haulcomb2, Lisa Tanzer3, Virginia M Sanders4, Kathryn J Jones2.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease involving progressive loss of motoneurons (MN). Axonal pathology and presynaptic deaf-ferentation precede MN degeneration during disease progression in patients and the ALS mouse model (mSOD1). Previously, we determined that a functional adaptive immune response is required for complete functional recovery following a facial nerve crush axotomy in wild-type (WT) mice. In this study, we investigated the effects of facial nerve crush axotomy on functional recovery and facial MN survival in presymptomatic mSOD1 mice, relative to WT mice. The results indicate that functional recovery and facial MN survival levels are significantly reduced in presymptomatic mSOD1, relative to WT, and similar to what has previously been observed in immunodeficient mice. It is concluded that a potential immune system defect exists in the mSOD1 mouse that negatively impacts neuronal survival and regeneration following target disconnection associated with peripheral nerve axotomy.

Entities:  

Keywords:  ALS; Axotomy; Functional recovery; Motoneuron survival; SOD1

Year:  2013        PMID: 24672589      PMCID: PMC3963697     

Source DB:  PubMed          Journal:  J Neurodegener Regen


  39 in total

1.  Differential expression between synaptic vesicle proteins and presynaptic plasma membrane proteins in the anterior horn of amyotrophic lateral sclerosis.

Authors:  Akito Ikemoto; Shinichi Nakamura; Ichiro Akiguchi; Asao Hirano
Journal:  Acta Neuropathol       Date:  2001-11-10       Impact factor: 17.088

Review 2.  Using comparative anatomy in the axotomy model to identify distinct roles for microglia and astrocytes in synaptic stripping.

Authors:  Shozo Jinno; Jun Yamada
Journal:  Neuron Glia Biol       Date:  2012-01-05

Review 3.  Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.

Authors:  N Shibata
Journal:  Neuropathology       Date:  2001-03       Impact factor: 1.906

4.  Differential macrophage responses in the peripheral and central nervous system during wallerian degeneration of axons.

Authors:  A M Avellino; D Hart; A T Dailey; M MacKinnon; D Ellegala; M Kliot
Journal:  Exp Neurol       Date:  1995-12       Impact factor: 5.330

5.  Differential gene expression in the axotomized facial motor nucleus of presymptomatic SOD1 mice.

Authors:  Nichole A Mesnard; Virginia M Sanders; Kathryn J Jones
Journal:  J Comp Neurol       Date:  2011-12-01       Impact factor: 3.215

6.  Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.

Authors:  Isaac M Chiu; Hemali Phatnani; Michael Kuligowski; Juan C Tapia; Monica A Carrasco; Ming Zhang; Tom Maniatis; Michael C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-20       Impact factor: 11.205

7.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

Authors:  H X Deng; A Hentati; J A Tainer; Z Iqbal; A Cayabyab; W Y Hung; E D Getzoff; P Hu; B Herzfeldt; R P Roos
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

Review 8.  Inflammatory processes in amyotrophic lateral sclerosis.

Authors:  P L McGeer; E G McGeer
Journal:  Muscle Nerve       Date:  2002-10       Impact factor: 3.217

9.  Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process.

Authors:  Stefania Mantovani; Silvia Garbelli; Alessandra Pasini; Dario Alimonti; Cesare Perotti; Mario Melazzini; Caterina Bendotti; Gabriele Mora
Journal:  J Neuroimmunol       Date:  2009-05-29       Impact factor: 3.478

10.  Altered reaction of facial motoneurons to axonal damage in the presymptomatic phase of a murine model of familial amyotrophic lateral sclerosis.

Authors:  R Mariotti; L Cristino; C Bressan; S Boscolo; M Bentivoglio
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

View more
  6 in total

1.  Facial nerve axotomy in mice: a model to study motoneuron response to injury.

Authors:  Deborah N Olmstead; Nichole A Mesnard-Hoaglin; Richard J Batka; Melissa M Haulcomb; Whitney M Miller; Kathryn J Jones
Journal:  J Vis Exp       Date:  2015-02-23       Impact factor: 1.355

2.  Impact of peripheral immune status on central molecular responses to facial nerve axotomy.

Authors:  D O Setter; E M Runge; N D Schartz; F M Kennedy; B L Brown; K P McMillan; W M Miller; K M Shah; M M Haulcomb; V M Sanders; K J Jones
Journal:  Brain Behav Immun       Date:  2017-10-10       Impact factor: 7.217

Review 3.  CD4 + T Cells and Neuroprotection: Relevance to Motoneuron Injury and Disease.

Authors:  Kathryn J Jones; Amy E Lovett-Racke; Chandler L Walker; Virginia M Sanders
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-07       Impact factor: 4.147

4.  Identification of B6SJL mSOD1(G93A) mouse subgroups with different disease progression rates.

Authors:  Melissa M Haulcomb; Nichole A Mesnard-Hoaglin; Richard J Batka; Rena M Meadows; Whitney M Miller; Kathryn P Mcmillan; Todd J Brown; Virginia M Sanders; Kathryn J Jones
Journal:  J Comp Neurol       Date:  2015-06-22       Impact factor: 3.215

5.  Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the SOD1G37R ALS Mouse Model.

Authors:  Éric Martineau; Danielle Arbour; Joanne Vallée; Richard Robitaille
Journal:  J Neurosci       Date:  2020-08-28       Impact factor: 6.167

6.  SOD1(G93A) transgenic mouse CD4(+) T cells mediate neuroprotection after facial nerve axotomy when removed from a suppressive peripheral microenvironment.

Authors:  Nichole A Mesnard-Hoaglin; Junping Xin; Melissa M Haulcomb; Richard J Batka; Virginia M Sanders; Kathryn J Jones
Journal:  Brain Behav Immun       Date:  2014-06-06       Impact factor: 7.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.